Next Article in Journal
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
Next Article in Special Issue
Brevilin A, a Sesquiterpene Lactone, Inhibits the Replication of Influenza A Virus In Vitro and In Vivo
Previous Article in Journal
Novel Tick Phlebovirus Genotypes Lacking Evidence for Vertebrate Infections in Anatolia and Thrace, Turkey
Previous Article in Special Issue
Anti-Respiratory Syncytial Virus Activity of Plantago asiatica and Clerodendrum trichotomum Extracts In Vitro and In Vivo
Open AccessReview

Human Antimicrobial Peptides as Therapeutics for Viral Infections

1
National Center for Biodefense and Infectious Disease, School of Systems Biology, George Mason University, Manassas, VA 20110, USA
2
United States Military Academy, West Point, NY 10996, USA
*
Author to whom correspondence should be addressed.
Viruses 2019, 11(8), 704; https://doi.org/10.3390/v11080704
Received: 28 May 2019 / Revised: 26 July 2019 / Accepted: 30 July 2019 / Published: 1 August 2019
(This article belongs to the Special Issue Antiviral Agents)
Successful in vivo infection following pathogen entry requires the evasion and subversion of multiple immunological barriers. Antimicrobial peptides (AMPs) are one of the first immune pathways upregulated during infection by multiple pathogens, in multiple organs in vivo. In humans, there are many classes of AMPs exhibiting broad antimicrobial activities, with defensins and the human cathelicidin LL-37 being the best studied examples. Whereas historically the efficacy and therapeutic potential of AMPs against bacterial infection has been the primary focus of research, recent studies have begun to elucidate the antiviral properties of AMPs as well as their role in regulation of inflammation and chemoattraction. AMPs as therapeutic tools seem especially promising against emerging infectious viral pathogens for which no approved vaccines or treatments are currently available, such as dengue virus (DENV) and Zika virus (ZIKV). In this review, we summarize recent studies elucidating the efficacy and diverse mechanisms of action of various classes of AMPs against multiple viral pathogens, as well as the potential use of human AMPs in novel antiviral therapeutic strategies. View Full-Text
Keywords: human antimicrobial peptides; antiviral strategies; defensins; cathelicidins; hepcidins; transferrins human antimicrobial peptides; antiviral strategies; defensins; cathelicidins; hepcidins; transferrins
MDPI and ACS Style

Ahmed, A.; Siman-Tov, G.; Hall, G.; Bhalla, N.; Narayanan, A. Human Antimicrobial Peptides as Therapeutics for Viral Infections. Viruses 2019, 11, 704. https://doi.org/10.3390/v11080704

AMA Style

Ahmed A, Siman-Tov G, Hall G, Bhalla N, Narayanan A. Human Antimicrobial Peptides as Therapeutics for Viral Infections. Viruses. 2019; 11(8):704. https://doi.org/10.3390/v11080704

Chicago/Turabian Style

Ahmed, Aslaa; Siman-Tov, Gavriella; Hall, Grant; Bhalla, Nishank; Narayanan, Aarthi. 2019. "Human Antimicrobial Peptides as Therapeutics for Viral Infections" Viruses 11, no. 8: 704. https://doi.org/10.3390/v11080704

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop